This effect substantially weakened in the post-S1 blood sample (Treatment Time S1 meal type S2 meal type interaction in the main model: t 50.0 = 2.61, p = 0.012), though BGL was still significantly lower under Ex compared to Vehicle control treatment (post-S1, Treatment: F 1,4.1 = 24.23, p = 0.0073)
These are not the same as the FDA-approved versions and come with different safety considerations
No pancreatitis as a separate question (only pancreas surgery appears in the surgery list)
Prescribing for this indication is currently off-label but medically and legally appropriate when clinical criteria are met
In the context of rheumatic diseases, ingredients such as vitamin C, zinc, and magnesium in IV drips may play a supportive role
Summary: While early studies found evidence of modest benefit, later and larger studies failed to find ALCAR effective for established dementia [15]